Detection of circulating tumor cells

Detection of circulating tumor cells in sufferers with breast most cancers utilizing the conditionally reprogrammed cell tradition methodology and reverse transcription-PCR of hTERT and MAGE A1-6

The current research aimed to confirm the efficacy of the conditionally reprogrammed cell (CRC) tradition methodology for the detection of circulating tumor cells (CTCs) in breast most cancers. CTCs have been remoted from the peripheral blood of sufferers with breast most cancers, and tradition of the collected CTCs was carried out in response to the conditional reprogramming protocol.

• Whole RNA was extracted from cultured CTCs, and the hTERT and MAGE A1-6 genes have been amplified utilizing reverse transcription-PCR (RT-PCR). As well as, RNA extraction from one other blood pattern was carried out and the expression of the 2 genes was analyzed by RT-PCR solely.
  
• Following CRC tradition, grown CTCs have been noticed in 7 samples (23.3%). The CTC detection charges by RT-PCR for the hTERT and MAGE A1-6 genes in CTCs grown utilizing the CRC tradition methodology have been 26.7 and 10.0%, respectively.
  
• The optimistic expression charges for the hTERT and MAGE genes in CTCs assessed by RT-PCR solely have been 44.1 and 23.5%, respectively. When combining the optimistic expression charges of RT-PCR solely and CRC tradition for the hTERT and MAGE A1-6 genes, CTC detection charges elevated to 53.Three and 23.3%, respectively. Moreover, when combining the optimistic expression charges of the 2 genes by both methodology, the CTC detection price was the best worth noticed.
  
• In conclusion, the current research revealed the potential of CRC tradition within the detection of CTCs in breast most cancers. Moreover, a mixture of CRC tradition and RT-PCR for the hTERT and MAGE A1-6 genes is helpful in enhancing the detection price of CTCs within the blood.

GPR81 antibody
70R-50946	Fitzgerald	100 ul	EUR 244
Description: Purified Polyclonal GPR81 antibody

GPR81 Antibody
ABD2766	Lifescience Market	100 ug	EUR 438

GPR81 Antibody
44942-100ul	SAB	100ul	EUR 252

GPR81 Antibody
44942-50ul	SAB	50ul	EUR 187

GPR81 antibody
20R-GR037	Fitzgerald	50 ug	EUR 679
Description: Rabbit polyclonal GPR81 antibody

GPR81 antibody
20R-GR038	Fitzgerald	50 ug	EUR 679
Description: Rabbit polyclonal GPR81 antibody

GPR81 Antibody
DF2766	Affbiotech	200ul	EUR 304
Description: GPR81 antibody detects endogenous levels of total GPR81.

Rabbit Polyclonal antibody Anti-CRBN
Anti-CRBN	ImmunoStep	50 µg	EUR 349

Polyclonal Goat Anti-GPR81 / FKSG80 Antibody
APR16285G	Leading Biology	0.1 mg	EUR 484
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GPR81 / FKSG80 . This antibody is tested and proven to work in the following applications:

GPR81 Conjugated Antibody
C44942	SAB	100ul	EUR 397

GPR81 Blocking Peptide
20-abx063821	Abbexa	EUR 272.00 EUR 411.00	1 mg 5 mg
Shipped within 5-10 working days.

GPR81 Blocking Peptide
DF2766-BP	Affbiotech	1mg	EUR 195

pDNR-Dual-GPR81
PVT17473	Lifescience Market	2 ug	EUR 231

Polyclonal GPR81 Antibody (C-term)
APR16611G	Leading Biology	0.1ml	EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR81 (C-term). This antibody is tested and proven to work in the following applications:

GPR81 ELISA KIT|Human
EF009971	Lifescience Market	96 Tests	EUR 689

Polyclonal Goat anti-GST α-form
GST-ANTI-1	Detroit R&D	50 uL	EUR 280

Polyclonal Goat anti-GST μ-form
GST-ANTI-2	Detroit R&D	50 uL	EUR 280

Polyclonal Goat anti-GST p-form
GST-ANTI-3	Detroit R&D	50 uL	EUR 280

Polyclonal FKSG80 / GPR81 Antibody (C-Terminus)
APR15995G	Leading Biology	0.05mg	EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal FKSG80 / GPR81 Antibody (Extracellular Domain)
APR15996G	Leading Biology	0.05mg	EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (Extracellular Domain). This antibody is tested and proven to work in the following applications:

Polyclonal FKSG80 / GPR81 Antibody (N-Terminus)
APR15997G	Leading Biology	0.05mg	EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (N-Terminus). This antibody is tested and proven to work in the following applications:

G Protein-Coupled Receptor 81 (GPR81) Antibody
20-abx147554	Abbexa	EUR 425.00 EUR 342.00	100 ug 50 ug
Shipped within 5-10 working days.

G Protein-Coupled Receptor 81 (GPR81) Antibody
20-abx008192	Abbexa	EUR 300.00 EUR 439.00 EUR 189.00	100 ul 200 ul 30 ul
Shipped within 5-10 working days.

G Protein-Coupled Receptor 81 (GPR81) Antibody
abx028676-400ul	Abbexa	400 ul	EUR 523
Shipped within 5-10 working days.

G Protein-Coupled Receptor 81 (GPR81) Antibody
abx028676-80l	Abbexa	80 µl	EUR 286
Shipped within 5-10 working days.

G Protein-Coupled Receptor 81 (GPR81) Antibody
abx430538-200ul	Abbexa	200 ul	EUR 384
Shipped within 1-3 working days.

G Protein-Coupled Receptor 81 (GPR81) Antibody
abx233610-100ug	Abbexa	100 ug	EUR 551
Shipped within 5-12 working days.

Gpr81 ORF Vector (Rat) (pORF)
ORF067824	ABM	1.0 ug DNA	EUR 506

Gpr81 ORF Vector (Mouse) (pORF)
ORF046573	ABM	1.0 ug DNA	EUR 506

GPR81 sgRNA CRISPR Lentivector set (Human)
K0893201	ABM	3 x 1.0 ug	EUR 339

Gpr81 sgRNA CRISPR Lentivector set (Rat)
K6130201	ABM	3 x 1.0 ug	EUR 339

Gpr81 sgRNA CRISPR Lentivector set (Mouse)
K3904701	ABM	3 x 1.0 ug	EUR 339

GPR81 sgRNA CRISPR Lentivector (Human) (Target 1)
K0893202	ABM	1.0 ug DNA	EUR 154

GPR81 sgRNA CRISPR Lentivector (Human) (Target 2)
K0893203	ABM	1.0 ug DNA	EUR 154

GPR81 sgRNA CRISPR Lentivector (Human) (Target 3)
K0893204	ABM	1.0 ug DNA	EUR 154

Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 1)
K6130202	ABM	1.0 ug DNA	EUR 154

Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 2)
K6130203	ABM	1.0 ug DNA	EUR 154

Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 3)
K6130204	ABM	1.0 ug DNA	EUR 154

Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K3904702	ABM	1.0 ug DNA	EUR 154

Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 2)
K3904703	ABM	1.0 ug DNA	EUR 154

Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K3904704	ABM	1.0 ug DNA	EUR 154

GPR81 Protein Vector (Rat) (pPB-C-His)
PV271294	ABM	500 ng	EUR 603

GPR81 Protein Vector (Rat) (pPB-N-His)
PV271295	ABM	500 ng	EUR 603

GPR81 Protein Vector (Rat) (pPM-C-HA)
PV271296	ABM	500 ng	EUR 603

GPR81 Protein Vector (Rat) (pPM-C-His)
PV271297	ABM	500 ng	EUR 603

GPR81 Protein Vector (Mouse) (pPB-C-His)
PV186290	ABM	500 ng	EUR 603

GPR81 Protein Vector (Mouse) (pPB-N-His)
PV186291	ABM	500 ng	EUR 603

GPR81 Protein Vector (Mouse) (pPM-C-HA)
PV186292	ABM	500 ng	EUR 603

GPR81 Protein Vector (Mouse) (pPM-C-His)
PV186293	ABM	500 ng	EUR 603

Gpr81 3'UTR Luciferase Stable Cell Line
TU205392	ABM	1.0 ml	Ask for price

Gpr81 3'UTR GFP Stable Cell Line
TU159042	ABM	1.0 ml	Ask for price

GPR81 3'UTR Luciferase Stable Cell Line
TU009183	ABM	1.0 ml	EUR 1521

Gpr81 3'UTR Luciferase Stable Cell Line
TU109042	ABM	1.0 ml	Ask for price

GPR81 3'UTR GFP Stable Cell Line
TU059183	ABM	1.0 ml	EUR 1521

Gpr81 3'UTR GFP Stable Cell Line
TU255392	ABM	1.0 ml	Ask for price

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K0893205	ABM	3 x 1.0 ug	EUR 376

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
K6130205	ABM	3 x 1.0 ug	EUR 376

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
K3904705	ABM	3 x 1.0 ug	EUR 376

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
K0893206	ABM	1.0 ug DNA	EUR 167

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
K0893207	ABM	1.0 ug DNA	EUR 167

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
K0893208	ABM	1.0 ug DNA	EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
K6130206	ABM	1.0 ug DNA	EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
K6130207	ABM	1.0 ug DNA	EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
K6130208	ABM	1.0 ug DNA	EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
K3904706	ABM	1.0 ug DNA	EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
K3904707	ABM	1.0 ug DNA	EUR 167

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)
K3904708	ABM	1.0 ug DNA	EUR 167

Anti-Anti-SEPT2 Antibody antibody
STJ28365	St John's Laboratory	100 µl	EUR 277

Anti-Anti-SEPT7 Antibody antibody
STJ28963	St John's Laboratory	100 µl	EUR 277
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.

Anti-Anti-SEPT6 antibody antibody
STJ11100949	St John's Laboratory	100 µl	EUR 277
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined.

Anti-Anti-SEPT2 Antibody antibody
STJ25475	St John's Laboratory	100 µl	EUR 277

Anti-Anti-SEPT5 Antibody antibody
STJ25477	St John's Laboratory	100 µl	EUR 277
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.

Anti-Anti-SEPT8 Antibody antibody
STJ25479	St John's Laboratory	100 µl	EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-SEPT9 Antibody antibody
STJ111369	St John's Laboratory	100 µl	EUR 277
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.

Anti-Anti-SEPT11 Antibody antibody
STJ111530	St John's Laboratory	100 µl	EUR 277

Anti-Anti-SEPT4 Antibody antibody
STJ112276	St John's Laboratory	100 µl	EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer.

Anti-Anti-MARCH9 Antibody antibody
STJ112609	St John's Laboratory	100 µl	EUR 277

Anti-Anti-SEPT11 Antibody antibody
STJ113941	St John's Laboratory	100 µl	EUR 277

Anti-Anti-SEPT11 Antibody antibody
STJ114081	St John's Laboratory	100 µl	EUR 277

Anti-Anti-SEPT5 Antibody antibody
STJ114819	St John's Laboratory	100 µl	EUR 277
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.

Anti-Anti-MARCH8 Antibody antibody
STJ114828	St John's Laboratory	100 µl	EUR 277

Anti-Anti-MARCH6 Antibody antibody
STJ118549	St John's Laboratory	100 µl	EUR 277

Anti-Anti-MARCH6 Antibody antibody
STJ118550	St John's Laboratory	100 µl	EUR 277

Anti-Anti-MARCH7 Antibody antibody
STJ118752	St John's Laboratory	100 µl	EUR 277

Anti-Anti-SEPT3 Antibody antibody
STJ118990	St John's Laboratory	100 µl	EUR 277

Anti-Anti-SEPT1 antibody antibody
STJ119580	St John's Laboratory	100 µl	EUR 277
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012]

Anti-Anti-SEPT7 Antibody antibody
STJ116214	St John's Laboratory	100 µl	EUR 277
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.

Anti-Anti-SEPT8 Antibody antibody
STJ117206	St John's Laboratory	100 µl	EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-SEPT12 Antibody antibody
STJ117759	St John's Laboratory	100 µl	EUR 277
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-DDB1 Antibody
A00333	BosterBio	100uL	EUR 455
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-10x96wellstestplate	Cloud-Clone	10x96-wells test plate	EUR 5647.8
The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) were tested on 3 different plates, 8 replicates in each plate CV(%) = SD/meanX100 Intra-Assay: CV<10% Int Show more
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-1x48wellstestplate	Cloud-Clone	1x48-wells test plate	EUR 552.76
The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) were tested on 3 different plates, 8 replicates in each plate CV(%) = SD/meanX100 Intra-Assay: CV<10% Int Show more
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-1x96wellstestplate	Cloud-Clone	1x96-wells test plate	EUR 746.8
The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) were tested on 3 different plates, 8 replicates in each plate CV(%) = SD/meanX100 Intra-Assay: CV<10% Int Show more
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-5x96wellstestplate	Cloud-Clone	5x96-wells test plate	EUR 3060.6
The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) were tested on 3 different plates, 8 replicates in each plate CV(%) = SD/meanX100 Intra-Assay: CV<10% Int Show more
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
4-AEA465Hu	Cloud-Clone	EUR 5698.00 EUR 3011.00 EUR 747.00	10 plates of 96 wells 5 plates of 96 wells 1 plate of 96 wells
Known also as Anti-Sperm Antibody elisa. Alternative names of the recognized antigen: Anti-Spermatozoa Antibodies Sperm Antibodies Antisperm Antibodies
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

ELISA kit for Human Anti-AsAb (Anti-Anti-Sperm Antibody Antibody)
ELK8071	ELK Biotech	1 plate of 96 wells	EUR 432
The microtiter plate provided in this kit has been pre-coated with an antigen. Standards or samples are then added to the appropriate microtiter plate wells with a Horseradish Peroxidase (HRP)-conjugated secondary antibody. After TMB substrate soluti Show more
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Anti-HAMA Antibody
E61I006	EnoGene	1mg	EUR 349

anti- ASH2L antibody
FNab00637	FN Test	100µg	EUR 505.25
Immunogen: ash2(absent, small, or homeotic)-like(Drosophila) Uniprot ID: Q9UBL3 Gene ID: 9070 Research Area: Epigenetics, Metabolism
Description: Antibody raised against ASH2L

anti- ASIC2 antibody
FNab00638	FN Test	100µg	EUR 505.25
Recommended dilution: WB: 1:200-1:1000 Immunogen: amiloride-sensitive cation channel 1, neuronal Uniprot ID: Q16515 Gene ID: 40 Research Area: Neuroscience
Description: Antibody raised against ASIC2

anti- ASIC4 antibody
FNab00639	FN Test	100µg	EUR 505.25
Recommended dilution: WB: 1:200-1:1000 Immunogen: amiloride-sensitive cation channel 4, pituitary Uniprot ID: Q96FT7 Gene ID: 55515 Research Area: Neuroscience
Description: Antibody raised against ASIC4

anti- ASK1 antibody
FNab00640	FN Test	100µg	EUR 505.25
Recommended dilution: WB: 1:100-1:1000 Immunogen: mitogen-activated protein kinase kinase kinase 5 Uniprot ID: Q99683 Gene ID: 4217 Research Area: Immunology, Cardiovascular, Metabolism
Description: Antibody raised against ASK1

anti- ASL antibody
FNab00641	FN Test	100µg	EUR 505.25
Recommended dilution: WB: 1:200-1:1000 IHC: 1:100-1:500 Immunogen: argininosuccinate lyase Uniprot ID: P04424 Gene ID: 435 Research Area: Metabolism
Description: Antibody raised against ASL

anti- ASMTL antibody
FNab00642	FN Test	100µg	EUR 505.25
Recommended dilution: WB: 1:500 - 1:2000 IHC: 1:50 - 1:200 IP: 1:50 - 1:200 Immunogen: acetylserotonin O-methyltransferase-like Uniprot ID: O95671 Gene ID: 8623 Research Area: Metabolism
Description: Antibody raised against ASMTL

anti- ASNA1 antibody
FNab00643	FN Test	100µg	EUR 505.25
Recommended dilution: WB: 1:200 - 1:2000 IHC: 1:50 - 1:200 Immunogen: arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) Uniprot ID: O43681 Gene ID: 439 Research Area: Metabolism
Description: Antibody raised against ASNA1

anti- ASNS antibody
FNab00644	FN Test	100µg	EUR 505.25
Recommended dilution: WB: 1:500-1:2000 IP: 1:500-1:1000 Immunogen: asparagine synthetase Uniprot ID: P08243 Gene ID: 440 Research Area: Metabolism
Description: Antibody raised against ASNS

anti- ASPA antibody
FNab00645	FN Test	100µg	EUR 505.25
Recommended dilution: WB: 1:500-1:1000 IHC: 1:50-1:500 Immunogen: aspartoacylase(Canavan disease) Uniprot ID: P45381 Gene ID: 443 Research Area: Metabolism
Description: Antibody raised against ASPA

Incidence, scientific course and threat issue for recurrent PCR positivity in discharged COVID-19 sufferers in Guangzhou, China: A potential cohort research

The phenomenon of COVID-19 sufferers examined optimistic for SARS-CoV-2 after discharge (redetectable as optimistic, RP) emerged globally. The information of incidence price and threat elements for RP occasion and the scientific options of RP sufferers might present suggestions for virus containment and circumstances administration for COVID-19.

We prospectively collected and analyzed the epidemiological, scientific and virological information from 285 grownup sufferers with COVID-19 and bought their particular scientific final result (getting PCR optimistic or not throughout post-discharge surveillance). By March 10, 27 (9.5%) discharged sufferers had examined optimistic for SARS-CoV-2 of their nasopharyngeal swab after a median length of seven·Zero days (IQR 5·0-8·0).

In comparison with first admission, RP sufferers typically had milder scientific signs, decrease viral load, shorter size of keep and improved pulmonary circumstances at readmission (p<0.05). Elder RP sufferers (≥ 60 years previous) have been extra prone to be symptomatic in comparison with youthful sufferers (7/8, 87.5% vs. 3/19, 18.8%, p = 0.001) at readmission.

Age, intercourse, epidemiological historical past, scientific signs and underlying illnesses have been related between RP and non-RP sufferers (p>0.05). A protracted length of viral shedding (>10 days) throughout the first hospitalization [adjusted odds ratio [aOR]: 5.82, 95% confidence interval [CI]: 2.50-13.57 for N gene; aOR: 9.64, 95% CI: 3.91-23.73 for ORF gene] and better Ct worth (ORF) within the third week of the primary hospitalization (aOR: 0.69; 95% CI: 0.50-0.95) have been related to RP occasions.

In conclusion, RP occasions occurred in practically 10% of COVID-19 sufferers shortly after the detrimental checks, weren’t related to worsening signs and unlikely mirror reinfection. Sufferers’ lack of effectivity in virus clearance was a threat issue for RP end result. It’s noteworthy that elder RP sufferers (≥ 60 years previous) have been extra vulnerable to scientific signs at readmission.

Ovine Paratuberculosis: Seroprevalence and comparability of fecal tradition and direct fecal PCR assay

Johne’s illness is persistent, incurable illness, brought on by Mycobacterium avium subsp. paratuberculosis (MAP). Most research in Egypt targeted on incidence of the illness in cattle however few research have been reported presence of antibodies towards MAP in sheep. The current research decided the seroprevalence price of MAP amongst sheep in 4 Governorates and assessed the related threat elements to MAP-infection.

• The seroprevalence price of MAP amongst sheep was non-significant various between totally different Governorates, it was ranged between 3.75%-12.3%. The outcomes revealed that the seroprevalence price of the illness was considerably elevated in diarrheic sheep (11 %, 95 %CI: 7.2-16.2) throughout spring (15 %, 95 %CI: 8.3-25) and summer time (8%, 95 %CI: 4.13-13.8) seasons.
  
• Opposite, the age of sheep and make contact with with different ruminants like cattle or goats had non-significant impact of spreading of MAP-infection amongst sheep. The detection of MAP in feces of sheep was carried out utilizing tradition and PCR to find out the effectivity of each checks.
  
• The kappa check revealed good settlement between each checks for detection of MAP. The obtained discovering confirms the presence of MAP amongst sheep in Egypt. So, the suitable management measures ought to be taken to scale back spreading of the illness amongst sheep and cut back its financial losses.

RAIDD Blocking Peptide
3037BP-50	Biovision		EUR 153

NFkB Blocking Peptide
3038BP-50	Biovision		EUR 153

FADD Blocking Peptide
3039BP-50	Biovision		EUR 153

PBR Blocking Peptide
3044BP-50	Biovision		EUR 153

MBD4 Blocking Peptide
3056BP-50	Biovision		EUR 153

PRMT7 blocking peptide
3059BP-50	Biovision		EUR 153

DR4 Blocking Peptide
3061BP-50	Biovision		EUR 153

DR5 Blocking Peptide
3062BP-50	Biovision		EUR 153

CD40 Blocking Peptide
3072BP-50	Biovision		EUR 153

Calreticulin Blocking Peptide
3077BP-50	Biovision		EUR 153

PRMT6 Blocking Peptide
3086BP-50	Biovision		EUR 153

TCTN1 Blocking Peptide
3087BP-50	Biovision		EUR 153

TCTN1 Blocking Peptide
3088BP-50	Biovision		EUR 153

KLF4 Blocking Peptide
3089BP-50	Biovision		EUR 153

Lin28 Blocking Peptide
3091BP-50	Biovision		EUR 153

Hsp27 Blocking Peptide
3093BP-50	Biovision		EUR 153

Hsp60 Blocking Peptide
3094RBP-50	Biovision		EUR 153

Hsc70 Blocking Peptide
3095BP-50	Biovision		EUR 153

Hsp70 Blocking Peptide
3097BP-50	Biovision		EUR 153

SIRT7 Blocking Peptide
3099BP-50	Biovision		EUR 153

AT2 Blocking Peptide
30R-AA024	Fitzgerald	100 ug	EUR 241
Description: A synthetic AT2 Blocking peptide for use as a blocking control in assays to test for specificity of AT2 antibody, catalog no. 70R-AR006

UCP3 Blocking Peptide
30R-AU006	Fitzgerald	100 ug	EUR 241
Description: A synthetic UCP3 Blocking peptide for use as a blocking control in assays to test for specificity of UCP3 antibody, catalog no. 20R-UR003

PKA Blocking Peptide
3115BP-50	Biovision		EUR 153

Raf1 Blocking Peptide
3116BP-50	Biovision		EUR 153

Wee1 Blocking Peptide
3120BP-50	Biovision		EUR 153

Stat1 Blocking Peptide
3133RBP-50	Biovision		EUR 153

MAK10 Blocking Peptide
3134BP-50	Biovision		EUR 153

ACADM Blocking Peptide
3137BP-50	Biovision		EUR 153

ACADL Blocking Peptide
3139BP-50	Biovision		EUR 153

ACADSB Blocking Peptide
3150BP-50	Biovision		EUR 153

ACADSB Blocking Peptide
3157BP-50	Biovision		EUR 153

Survivin Blocking Peptide
3160BP-50	Biovision		EUR 153

TXNRD1 Blocking Peptide
7005BP-50	Biovision		EUR 153

EDEM2 Blocking Peptide
6633BP-50	Biovision		EUR 153

SPHKAP Blocking Peptide
6656BP-50	Biovision		EUR 153

USP8 Blocking Peptide
6658BP-50	Biovision		EUR 153

EHHADH Blocking Peptide
6678BP-50	Biovision		EUR 153

ACTH Blocking Peptide
A1051BP-50	Biovision		EUR 153

Secretin Blocking Peptide
A1054BP-50	Biovision		EUR 153

C16orf73 Blocking Peptide
33R-1811	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C16orf73 antibody, catalog no. 70R-4561

ITGBL1 Blocking Peptide
33R-1812	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ITGBL1 antibody, catalog no. 70R-1700

C6ORF21 Blocking Peptide
33R-1813	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C6orf21 antibody, catalog no. 70R-1743

PNPLA3 Blocking Peptide
33R-1814	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PNPLA3 antibody, catalog no. 70R-2371

SERPINF2 Blocking Peptide
33R-1815	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SERPINF2 antibody, catalog no. 70R-9700

SLC22A16 Blocking Peptide
33R-1816	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SLC22A16 antibody, catalog no. 70R-1824

MYLIP Blocking Peptide
33R-1817	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MYLIP antibody, catalog no. 70R-2736

PBEF1 Blocking Peptide
33R-1818	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PBEF1 antibody, catalog no. 70R-1027

WNT9B Blocking Peptide
33R-1820	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of WNT9B antibody, catalog no. 70R-7246

TM4SF4 Blocking Peptide
33R-1822	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TM4SF4 antibody, catalog no. 70R-7470

ZNF550 Blocking Peptide
33R-1823	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF550 antibody, catalog no. 20R-1242

SHROOM2 Blocking Peptide
33R-1824	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SHROOM2 antibody, catalog no. 70R-5079

LOC441964 Blocking Peptide
33R-1825	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LOC441964 antibody, catalog no. 70R-1024

ADRB1 Blocking Peptide
33R-1826	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ADRB1 antibody, catalog no. 70R-5939

TCP11 Blocking Peptide
33R-1827	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TCP11 antibody, catalog no. 70R-3950

KIF2B Blocking Peptide
33R-1828	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KIF2B antibody, catalog no. 70R-5498

RBJ Blocking Peptide
33R-1829	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RBJ antibody, catalog no. 70R-5875

MFI2 Blocking Peptide
33R-1830	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MFI2 antibody, catalog no. 70R-10040

UNC84B Blocking Peptide
33R-1831	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of UNC84B antibody, catalog no. 70R-6991

CLEC4M Blocking Peptide
33R-1832	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CLEC4M antibody, catalog no. 70R-8545

LAYN Blocking Peptide
33R-1833	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LAYN antibody, catalog no. 70R-7484

FKBP5 Blocking Peptide
33R-1834	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FKBP5 antibody, catalog no. 70R-2377

GJB6 Blocking Peptide
33R-1835	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GJB6 antibody, catalog no. 70R-6097

FZD5 Blocking Peptide
33R-1836	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FZD5 antibody, catalog no. 70R-7475

ELMOD1 Blocking Peptide
33R-1837	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ELMOD1 antibody, catalog no. 70R-9490

C9ORF127 Blocking Peptide
33R-1838	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf127 antibody, catalog no. 70R-7095

KIAA0692 Blocking Peptide
33R-1839	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA0692 antibody, catalog no. 70R-3254

OR13C5 Blocking Peptide
33R-1840	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of OR13C5 antibody, catalog no. 70R-7901

GINS2 Blocking Peptide
33R-1841	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GINS2 antibody, catalog no. 70R-5625

RGS16 Blocking Peptide
33R-1842	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RGS16 antibody, catalog no. 70R-1260

CACNB2 Blocking Peptide
33R-1843	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB2 antibody, catalog no. 70R-5063

DNER Blocking Peptide
33R-1844	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DNER antibody, catalog no. 20R-1277

RFPL3 Blocking Peptide
33R-1845	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RFPL3 antibody, catalog no. 70R-1162

PENK Blocking Peptide
33R-1846	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PENK antibody, catalog no. 70R-6226

DGKQ Blocking Peptide
33R-1847	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DGKQ antibody, catalog no. 70R-9133

NUDC Blocking Peptide
33R-1848	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NUDC antibody, catalog no. 70R-5520

PABPC5 Blocking Peptide
33R-1849	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PABPC5 antibody, catalog no. 70R-4840

TRAF1 Blocking Peptide
33R-1850	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TRAF1 antibody, catalog no. 70R-10512

ZPLD1 Blocking Peptide
33R-1851	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ZPLD1 antibody, catalog no. 70R-7542

SREBF1 Blocking Peptide
33R-1852	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SREBF1 antibody, catalog no. 70R-10526

ATG4A Blocking Peptide
33R-1853	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ATG4A antibody, catalog no. 70R-2866

KRT14 Blocking Peptide
33R-1854	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KRT14 antibody, catalog no. 20R-1352

POLDIP3 Blocking Peptide
33R-1855	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of POLDIP3 antibody, catalog no. 70R-4847

SRGAP1 Blocking Peptide
33R-1856	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SRGAP1 antibody, catalog no. 70R-9502

CYLC2 Blocking Peptide
33R-1857	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CYLC2 antibody, catalog no. 70R-2744

DKKL1 Blocking Peptide
33R-1858	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DKKL1 antibody, catalog no. 70R-7515

CHD1L Blocking Peptide
33R-1859	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CHD1L antibody, catalog no. 70R-1304

MYH9 Blocking Peptide
33R-1860	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MYH9 antibody, catalog no. 70R-2739

PTTG2 Blocking Peptide
33R-1861	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PTTG2 antibody, catalog no. 70R-8929

NFKBIE Blocking Peptide
33R-1862	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NFKBIE antibody, catalog no. 70R-8262

TMEM9 Blocking Peptide
33R-1863	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM9 antibody, catalog no. 70R-7412

CAPS Blocking Peptide
33R-1864	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CAPS antibody, catalog no. 70R-5864

RAD54B Blocking Peptide
33R-1865	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RAD54B antibody, catalog no. 70R-5648

OASL Blocking Peptide
33R-1866	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of OASL antibody, catalog no. 70R-5891

DMAP1 Blocking Peptide
33R-1867	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DMAP1 antibody, catalog no. 20R-1081

IGFALS Blocking Peptide
33R-1869	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of IGFALS antibody, catalog no. 70R-6072

GPX3 Blocking Peptide
33R-1870	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GPX3 antibody, catalog no. 70R-5305

THG1L Blocking Peptide
33R-1871	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of THG1L antibody, catalog no. 70R-3535

CCT5 Blocking Peptide
33R-1872	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CCT5 antibody, catalog no. 70R-3888

MBD2 Blocking Peptide
33R-1873	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MBD2 antibody, catalog no. 70R-1031

KIF2B Blocking Peptide
33R-1874	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KIF2B antibody, catalog no. 70R-5604

NANOS1 Blocking Peptide
33R-1875	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NANOS1 antibody, catalog no. 70R-4987

ZNF280C Blocking Peptide
33R-1876	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF280C antibody, catalog no. 70R-8333

Zfp161 Blocking Peptide
33R-1877	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Zfp161 antibody, catalog no. 70R-7991

SSR1 Blocking Peptide
33R-1878	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SSR1 antibody, catalog no. 70R-7311

LOC153222 Blocking Peptide
33R-1879	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LOC153222 antibody, catalog no. 70R-7905

ASB12 Blocking Peptide
33R-1880	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ASB12 antibody, catalog no. 70R-5841

NID2 Blocking Peptide
33R-1881	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NID2 antibody, catalog no. 70R-6064

ABCF3 Blocking Peptide
33R-1883	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ABCF3 antibody, catalog no. 70R-6278

SLC5A7 Blocking Peptide
33R-1884	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SLC5A7 antibody, catalog no. 70R-7211

HAO2 Blocking Peptide
33R-1885	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HAO2 antibody, catalog no. 70R-2913

Katna1 Blocking Peptide
33R-1887	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Katna1 antibody, catalog no. 70R-9162

C6ORF134 Blocking Peptide
33R-1888	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C6orf134 antibody, catalog no. 70R-3866

CPSF3 Blocking Peptide
33R-1889	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CPSF3 antibody, catalog no. 70R-1351

FBXO3 Blocking Peptide
33R-1890	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FBXO3 antibody, catalog no. 70R-2790

MPDZ Blocking Peptide
33R-1891	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MPDZ antibody, catalog no. 70R-2266

ARHGDIG Blocking Peptide
33R-1892	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ARHGDIG antibody, catalog no. 70R-6038

PDXDC1 Blocking Peptide
33R-1893	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PDXDC1 antibody, catalog no. 70R-4233

LDLRAD1 Blocking Peptide
33R-1894	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LDLRAD1 antibody, catalog no. 70R-6670

TAF7L Blocking Peptide
33R-1895	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TAF7L antibody, catalog no. 20R-1157

POLR3GL Blocking Peptide
33R-1896	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of POLR3GL antibody, catalog no. 70R-10078

LDLRAD3 Blocking Peptide
33R-1897	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LDLRAD3 antibody, catalog no. 70R-9224

ZGPAT Blocking Peptide
33R-1898	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ZGPAT antibody, catalog no. 70R-3509

Mcm10 Blocking Peptide
33R-1899	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Mcm10 antibody, catalog no. 70R-8186

HSPA1L Blocking Peptide
33R-1900	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HSPA1L antibody, catalog no. 70R-4431

SNRPN Blocking Peptide
33R-1901	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SNRPN antibody, catalog no. 70R-8478

DHRSX Blocking Peptide
33R-1902	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DHRSX antibody, catalog no. 70R-7875

TTC33 Blocking Peptide
33R-1903	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TTC33 antibody, catalog no. 70R-3754

CTAGE5 Blocking Peptide
33R-1904	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CTAGE5 antibody, catalog no. 70R-7102

CPEB4 Blocking Peptide
33R-1905	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CPEB4 antibody, catalog no. 70R-4969

FSIP1 Blocking Peptide
33R-1906	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FSIP1 antibody, catalog no. 70R-3397

DDX27 Blocking Peptide
33R-1907	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DDX27 antibody, catalog no. 70R-1385

ADD3 Blocking Peptide
33R-1908	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ADD3 antibody, catalog no. 70R-9940

C22ORF30 Blocking Peptide
33R-1909	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C22orf30 antibody, catalog no. 70R-4259

CHGN Blocking Peptide
33R-1910	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ChGn antibody, catalog no. 70R-6125

EIF2S2 Blocking Peptide
33R-1911	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EIF2S2 antibody, catalog no. 70R-4904

OAS2 Blocking Peptide
33R-1912	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of OAS2 antibody, catalog no. 70R-5885

Glycoprotein Blocking Peptide
33R-1913	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GPNMB antibody, catalog no. 70R-7234

MSH5 Blocking Peptide
33R-1915	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MSH5 antibody, catalog no. 70R-5579

DDX19B Blocking Peptide
33R-1916	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DDX19B antibody, catalog no. 70R-1379

PDS5B Blocking Peptide
33R-1917	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PDS5B antibody, catalog no. 70R-2864

C1QTNF4 Blocking Peptide
33R-1918	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C1QTNF4 antibody, catalog no. 70R-5423

AKAP7 Blocking Peptide
33R-1919	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of AKAP7 antibody, catalog no. 70R-3082

NRBP1 Blocking Peptide
33R-1920	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NRBP1 antibody, catalog no. 70R-9295

INTS12 Blocking Peptide
33R-1921	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of INTS12 antibody, catalog no. 70R-9072

FXYD5 Blocking Peptide
33R-1922	Fitzgerald	100 ug	EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FXYD5 antibody, catalog no. 70R-1683